77 results
8-K
EX-99.2
PSTX
Poseida Therapeutics Inc
17 Apr 24
Poseida Therapeutics Hosts Gene Therapy R&D Day Highlighting New Scientific Advancements and Pipeline Focus
9:17am
used today: are under clinical 2 improved safety; investigation Factor replacement therapy EHL products and a nonfactor therapy Factor VIII Bi-specific
8-K
EX-10.1
PSTX
Poseida Therapeutics Inc
4 Jan 24
Departure of Directors or Certain Officers
4:01pm
defense, prosecution, or investigation of any claims or demands by or against third parties, or other matters arising from events, acts, or failures
8-K
EX-10.3
PSTX
Poseida Therapeutics Inc
4 Jan 24
Departure of Directors or Certain Officers
4:01pm
fully with the Company in connection with its actual or contemplated defense, prosecution, or investigation of any claims or demands by or against third
8-K
EX-10.1
rrpbxz2bc88bqlg
7 Aug 23
Astellas and Poseida Therapeutics Announce Strategic
9:01am
8-K
EX-10.2
me8iwjq8qz5va5j6d
7 Aug 23
Astellas and Poseida Therapeutics Announce Strategic
9:01am
8-K
EX-1.1
6yktn5kentkl1pt
4 Aug 22
Poseida Therapeutics Announces Proposed Public Offering of Common Stock
4:57pm
8-K
EX-10.1
1cw 0pbawiogba6xzn
1 Feb 22
Departure of Directors or Certain Officers
4:23pm
8-K
EX-10.3
lxapv14bpq
1 Feb 22
Departure of Directors or Certain Officers
4:23pm